Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - peginterferoon beeta-1a - hulgiskleroos - immunostimulants, - täiskasvanud patsientidel on retsidiveeruva remiteriva sclerosis multiplex'i ravi.

Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - natalisumab - hulgiskleroos - selektiivsed immunosupressandid - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen naatrium - lihase atroofia, spinaalne - muud närvisüsteemi ravimid - spinraza on näidustatud spetsiaalse mussooni atroofia 5q raviks.

Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosis multiplex, relapsing-remitting - immunosupressandid - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Eesti - eesti - Ravimiamet

alvogen pharma trading europe eood - erlotiniib - õhukese polümeerikattega tablett - 100mg 30tk

Eesti - eesti - Ravimiamet

alvogen ipco s.a.r.l. - kapetsitabiin - õhukese polümeerikattega tablett - 500mg 120tk

Eesti - eesti - Ravimiamet

alvogen ipco s.a.r.l. - imatiniib - õhukese polümeerikattega tablett - 400mg 180tk; 400mg 20tk; 400mg 120tk; 400mg 30tk; 400mg 60tk; 400mg 10tk; 400mg 90tk

Eesti - eesti - Ravimiamet

alvogen ipco s.a.r.l. - kapetsitabiin - õhukese polümeerikattega tablett - 150mg 60tk

Eesti - eesti - Ravimiamet

alvogen pharma trading europe eood - erlotiniib - õhukese polümeerikattega tablett - 150mg 30tk

Eesti - eesti - Ravimiamet

alvogen ipco s.a.r.l. - temosolomiid - kõvakapsel - 250mg 20tk